Lista de obras - Jing Zhang - Dominio Público Uruguay

An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression

artículo científico publicado en 2017

Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform

artículo científico publicado en 2008

Biochemical premotor biomarkers for Parkinson's disease ⬇️

artículo científico publicado el 15 de abril de 2012

Biomarkers for cognitive impairment in Parkinson disease

artículo científico publicado en 2010

Blood alpha-synuclein in agricultural pesticide handlers in central Washington State

artículo científico publicado en 2015

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

artículo científico publicado en 2016

CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease

artículo científico publicado en 2015

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease ⬇️

artículo científico publicado el 29 de junio de 2013

Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease

artículo científico publicado en 2015

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

artículo científico publicado en 2011

Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort

artículo científico publicado en 2014

Characterization of proteome of human cerebrospinal fluid

artículo científico publicado en 2006

Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control

artículo científico publicado en 2013

Cognitive profile of LRRK2-related Parkinson's disease

artículo científico publicado en 2015

Coniferaldehyde attenuates Alzheimer's pathology via activation of Nrf2 and its targets

artículo científico publicado en 2020

Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span

artículo científico publicado en 2014

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

artículo científico publicado en 2010

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease

artículo científico publicado en 2012

Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment

artículo científico publicado en 2011

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

artículo científico publicado en 2019

Glycoproteomics in neurodegenerative diseases

artículo científico publicado en 2010

Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression

artículo científico publicado en 2009

Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells

artículo científico publicado en 2007

Identification of novel proteins associated with both alpha-synuclein and DJ-1

scientific journal article

Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers

artículo científico publicado en 2019

Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau.

artículo científico publicado en 2015

MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform

artículo científico publicado en 2010

Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

artículo científico publicado en 2008

Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases

scientific article published on 31 January 2019

Mortalin: a protein associated with progression of Parkinson disease?

artículo científico publicado en 2008

New windows into the brain: Central nervous system-derived extracellular vesicles in blood

scientific article published on 25 January 2019

Phosphorylated α-synuclein in Parkinson's disease

artículo científico publicado en 2012

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

artículo científico publicado en 2014

Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study

scientific article published on 27 April 2018

Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein

artículo científico publicado en 2005

Quantitative neuropathology associated with chronic manganese exposure in South African mine workers

artículo científico publicado en 2013

SNCA variant associated with Parkinson disease and plasma alpha-synuclein level

artículo científico publicado en 2010

Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease ⬇️

artículo científico publicado el 1 de enero de 2011

Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence

artículo científico publicado en 2013

Tau Proteins Cross the Blood-Brain Barrier

artículo científico publicado en 2016

Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?

artículo científico publicado en 2017

α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation

artículo científico publicado en 2015

Lista de obras de Jing Zhang

An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression

Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform

Biochemical premotor biomarkers for Parkinson's disease ⬇️

Biomarkers for cognitive impairment in Parkinson disease

Blood alpha-synuclein in agricultural pesticide handlers in central Washington State

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease

CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease ⬇️

Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort

Characterization of proteome of human cerebrospinal fluid

Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control

Cognitive profile of LRRK2-related Parkinson's disease

Coniferaldehyde attenuates Alzheimer's pathology via activation of Nrf2 and its targets

Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease

Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

Glycoproteomics in neurodegenerative diseases

Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression

Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells

Identification of novel proteins associated with both alpha-synuclein and DJ-1

Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers

Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau.

MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform

Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases

Mortalin: a protein associated with progression of Parkinson disease?

New windows into the brain: Central nervous system-derived extracellular vesicles in blood

Phosphorylated α-synuclein in Parkinson's disease

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study

Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein

Quantitative neuropathology associated with chronic manganese exposure in South African mine workers

SNCA variant associated with Parkinson disease and plasma alpha-synuclein level

Salivary Tau Species are Potential Biomarkers of Alzheimer's Disease ⬇️

Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence

Tau Proteins Cross the Blood-Brain Barrier

Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?

α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation